- Home
- FBRX vs RCMT Comparison
FBRX vs RCMT Comparison
Compare FBRX & RCMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- RCMT
- Stock Information
- Founded
- FBRX N/A
- RCMT 1971
- Country
- FBRX United States
- RCMT United States
- Employees
- FBRX N/A
- RCMT N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- RCMT Professional Services
- Sector
- FBRX Health Care
- RCMT Consumer Discretionary
- Exchange
- FBRX Nasdaq
- RCMT Nasdaq
- Market Cap
- FBRX 154.5M
- RCMT 172.2M
- IPO Year
- FBRX N/A
- RCMT N/A
- Fundamental
- Price
- FBRX $11.57
- RCMT $24.65
- Analyst Decision
- FBRX Strong Buy
- RCMT Strong Buy
- Analyst Count
- FBRX 2
- RCMT 2
- Target Price
- FBRX $61.00
- RCMT $33.50
- AVG Volume (30 Days)
- FBRX 53.8K
- RCMT 48.6K
- Earning Date
- FBRX 08-14-2025
- RCMT 08-06-2025
- Dividend Yield
- FBRX N/A
- RCMT N/A
- EPS Growth
- FBRX N/A
- RCMT N/A
- EPS
- FBRX N/A
- RCMT 1.76
- Revenue
- FBRX N/A
- RCMT $299,916,000.00
- Revenue This Year
- FBRX N/A
- RCMT $16.29
- Revenue Next Year
- FBRX N/A
- RCMT $6.16
- P/E Ratio
- FBRX N/A
- RCMT $13.98
- Revenue Growth
- FBRX N/A
- RCMT 11.01
- 52 Week Low
- FBRX $4.11
- RCMT $13.18
- 52 Week High
- FBRX $28.68
- RCMT $27.24
- Technical
- Relative Strength Index (RSI)
- FBRX 57.91
- RCMT 53.21
- Support Level
- FBRX $9.91
- RCMT $20.98
- Resistance Level
- FBRX $11.26
- RCMT $24.19
- Average True Range (ATR)
- FBRX 0.84
- RCMT 1.29
- MACD
- FBRX 0.15
- RCMT 0.03
- Stochastic Oscillator
- FBRX 88.53
- RCMT 71.54
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.